Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Hikata, T.
  • Takaishi, H.
  • Takito, J.
  • Hakozaki, A.
  • Furukawa, M.
  • Uchikawa, S.
  • Kimura, T.
  • Okada, Y.
  • Matsumoto, M.
  • Yoshimura, A.
  • Nishimura, R.
  • Reddy, S. V.
  • Asahara, Hiroshi
  • Toyama, Y.

publication date

  • March 2009

journal

  • Blood  Journal

abstract

  • Cytokine signaling via various transcription factors regulates receptor activator of nuclear factor (NF)-kappaB ligand (RANKL)-mediated osteoclast differentiation from monocyte/macrophage lineage cells involved in propagation and resolution of inflammatory bone destruction. Protein inhibitor of activated STAT3 (PIAS3) was initially identified as a molecule that inhibits DNA binding of STAT3 and regulates many transcription factors through distinct mechanisms. To analyze PIAS3 function in osteoclasts in vivo, we have generated transgenic mice in which PIAS3 is specifically expressed in the osteoclast lineage using the tartrate-resistant acid phosphatase (TRAP) gene promoter. PIAS3 transgenic mice showed an osteopetrotic phenotype due to impairment of osteoclast differentiation. Overexpression of PIAS3 in RAW264.7 cells suppressed RANKL-induced osteoclastogenesis by inhibiting the expression of c-Fos and NFATc1. Interestingly, PIAS3 inhibits the transcriptional activity of microphthalmia-associated transcription factor (MITF) independent of sumoylation. Down-regulation of PIAS3 markedly enhances RANKL-mediated osteoclastogenesis in RAW264.7 cells. Furthermore, overexpression of PIAS3 in mouse primary osteoblast (POB), down-regulates RANKL expression induced by interleukin-6 (IL-6) cytokine family, and inhibits osteoclast formation from bone marrow macrophages (BMMs) in vitro coculture system. Down-regulation of PIAS3 leads to the accelerated expression of RANKL in POB stimulated with IL-6 and soluble IL-6 receptor (sIL-6R). Taken together, our results clearly indicate that PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.

subject areas

  • Animals
  • Blotting, Western
  • Cell Differentiation
  • Enzyme-Linked Immunosorbent Assay
  • Immunoprecipitation
  • Mice
  • Mice, Transgenic
  • Osteoblasts
  • Osteoclasts
  • Protein Inhibitors of Activated STAT
  • RANK Ligand
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stem Cells
  • X-Ray Microtomography
scroll to property group menus

Identity

PubMed Central ID

  • PMC3401028

International Standard Serial Number (ISSN)

  • 0006-4971

Digital Object Identifier (DOI)

  • 10.1182/blood-2008-06-162594

PubMed ID

  • 18952894
scroll to property group menus

Additional Document Info

start page

  • 2202

end page

  • 2212

volume

  • 113

issue

  • 10

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support